Addex Therapeutics Ltd (ADXN) reported Q3 EPS of ($0.09), in-line with the analyst estimate of ($0.09). Revenue for the quarter came in at $420 thousand versus the consensus estimate of $426.71 thousand.
Addex Therapeutics Ltd (ADXN) reported Q3 EPS of ($0.09), in-line with the analyst estimate of ($0.09). Revenue for the quarter came in at $420 thousand versus the consensus estimate of $426.71 thousand.